U Creutzig|D Hoelzer - JoVE Visualize

Showing results (81-90 of 410) with videos related to

Pageof 41

Sort By:

Leukemia|October 10, 1998

Duration of first remission predicts remission rates and long-term survival in children with relapsed acute myelogenous leukemiaK Stahnke, J Boos, C Bender-Götze, et al.

Klinische Padiatrie|September 23, 1998

[Prognosis of children with acute myelocytic leukemia after first relapse]U Creutzig, J Ritter, J Boos, et al.

Klinische Padiatrie|April 29, 2005

[The "quality house pediatric oncology" as an instrument for improving the performance of the trial centers]U Creutzig, J Hannemann, I Krämer, et al.

Klinische Padiatrie|May 24, 2013

Development of a curative treatment within the AML-BFM studiesU Creutzig, M Zimmermann, M N Dworzak, et al.

Klinische Padiatrie|September 3, 1999

[Computer-assisted documentation and therapy planning in pediatric oncology--introduction of a nationwide solution]P Knaup, T Wiedemann, A Wolff, et al.

Klinische Padiatrie|July 1, 1993

[Classification of AML by morphologic, immunologic and cytogenetic criteria. Review with reference to subtypes in the AML-BFM-87 study]U Creutzig, J Ritter, W D Ludwig, et al.

Cytogenetics and Cell Genetics|November 27, 1999

High resolution physical mapping of human HDAC3, a potential tumor suppressor gene in the 5q31 regionU Mahlknecht, R Bucala, D Hoelzer, et al.

Biochemical and Biophysical Research Communications|September 24, 1999

Cloning and characterization of the murine histone deacetylase (HDAC3)U Mahlknecht, D Hoelzer, R Bucala, et al.

Leukemia|February 12, 1999

Megakaryocytic growth factors: is there a new approach for management of thrombocytopenia in patients with malignancies?W K Hofmann, O G Ottmann, D Hoelzer

Cancer Genetics and Cytogenetics|June 1, 1982

Ph1 -positive CML associated with megakaryocytic hyperplasia and thrombocythemia and an abnormality of chromosome no. 3F Carbonell, D Hoelzer, E Thiel, et al.

Pageof 41

Showing results (81-90 of 410) with videos related to

Sort By:

Pageof 41

Leukemia|October 10, 1998

Duration of first remission predicts remission rates and long-term survival in children with relapsed acute myelogenous leukemiaK Stahnke, J Boos, C Bender-Götze, et al.

Klinische Padiatrie|September 23, 1998

[Prognosis of children with acute myelocytic leukemia after first relapse]U Creutzig, J Ritter, J Boos, et al.

Klinische Padiatrie|April 29, 2005

[The "quality house pediatric oncology" as an instrument for improving the performance of the trial centers]U Creutzig, J Hannemann, I Krämer, et al.

Klinische Padiatrie|May 24, 2013

Development of a curative treatment within the AML-BFM studiesU Creutzig, M Zimmermann, M N Dworzak, et al.

Klinische Padiatrie|September 3, 1999

[Computer-assisted documentation and therapy planning in pediatric oncology--introduction of a nationwide solution]P Knaup, T Wiedemann, A Wolff, et al.

Klinische Padiatrie|July 1, 1993

[Classification of AML by morphologic, immunologic and cytogenetic criteria. Review with reference to subtypes in the AML-BFM-87 study]U Creutzig, J Ritter, W D Ludwig, et al.

Cytogenetics and Cell Genetics|November 27, 1999

High resolution physical mapping of human HDAC3, a potential tumor suppressor gene in the 5q31 regionU Mahlknecht, R Bucala, D Hoelzer, et al.

Biochemical and Biophysical Research Communications|September 24, 1999

Cloning and characterization of the murine histone deacetylase (HDAC3)U Mahlknecht, D Hoelzer, R Bucala, et al.

Leukemia|February 12, 1999

Megakaryocytic growth factors: is there a new approach for management of thrombocytopenia in patients with malignancies?W K Hofmann, O G Ottmann, D Hoelzer

Cancer Genetics and Cytogenetics|June 1, 1982

Ph1 -positive CML associated with megakaryocytic hyperplasia and thrombocythemia and an abnormality of chromosome no. 3F Carbonell, D Hoelzer, E Thiel, et al.

Pageof 41